Mrv1652310211604112D 17 18 0 0 1 0 999 V2000 -0.6078 4.3527 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.6078 3.5277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.3222 3.1152 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -2.0367 3.5277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.7512 3.1152 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -2.0367 4.3527 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.3222 4.7652 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.3222 5.5902 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.3222 2.2902 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 -0.6548 1.8053 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 -0.9097 1.0206 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 -1.7347 1.0206 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 -1.9897 1.8053 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -2.2197 0.3532 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.8841 -0.4005 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.4248 0.3532 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.1298 2.0602 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0 1 2 2 0 0 0 0 2 3 1 0 0 0 0 3 4 1 0 0 0 0 4 5 2 0 0 0 0 4 6 1 0 0 0 0 6 7 1 0 0 0 0 1 7 1 0 0 0 0 7 8 2 0 0 0 0 9 3 1 1 0 0 0 9 10 1 0 0 0 0 10 11 1 0 0 0 0 11 12 1 0 0 0 0 12 13 1 0 0 0 0 9 13 1 0 0 0 0 12 14 1 1 0 0 0 14 15 1 0 0 0 0 11 16 1 6 0 0 0 10 17 1 1 0 0 0 M END > DB13030 > drugbank > OC[C@H]1O[C@H]([C@@H](F)[C@@H]1O)N1C=CC(=O)NC1=O > InChI=1S/C9H11FN2O5/c10-6-7(15)4(3-13)17-8(6)12-2-1-5(14)11-9(12)16/h1-2,4,6-8,13,15H,3H2,(H,11,14,16)/t4-,6+,7-,8-/m1/s1 > UIYWFOZZIZEEKJ-PXBUCIJWSA-N > C9H11FN2O5 > 246.194 > 246.065199625 > 5 > 28 > 21.04859291441744 > 1 > 3 > 0 > 0 > 1-[(2R,3S,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione > -1.03 > -1.5241503676666666 > -0.31 > 0 > 2 > 0 > 12.73653356042107 > 9.850250725600388 > -2.9805440350358383 > 99.10000000000001 > 50.87350000000001 > 2 > 1 > 1.20e+02 g/l > 1-[(2R,3S,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-pyrimidine-2,4-dione > 0 > DB13030 > investigational > 2'-fluoro-5-ethylarabinosyluracil > 1-(2-Deoxy-2-fluoro-beta-D-arabinofuranosyl)uracil; 2'-Fluoro-5-ethyl-1-beta-D-arabinofuranosyluracil; FAU $$$$